The Meaningful Use Workgroup, part of the Health IT Policy Committee that advises Office of the National Coordinator for Health IT, has drafted recommendations for meaningful use stage 3 goals and criteria.
According to the recommendations, stage 3, scheduled for 2016 to 2017, should focus on using technology implemented in stages 1 and 2 to improve patient outcomes.
To this end, the workgroup recommends stage 3 address key gaps in electronic health record functionality, simplify meaningful use reporting requirements so that higher level objective compliance assumes subsumed process compliance and promote greater patient engagement.
Specific stage 3 objectives recommended include:
- Tracking more than 50 percent of medication orders electronically
- Providing the ability to electronically submit patient-generated data
- Tracking medical devices on 80 percent of implant patients
- Ensuring EHRs can assist with follow-up orders and identify potentially appropriate clinical trials
- Sending electronic notifications to a patient’s primary care provider or other member of the care team following a significant healthcare event (such as emergency department admission)
The report also suggested some objectives may need to be postponed to a future stage beyond stage 3.
More Articles on Meaningful Use:
CMS: 7,500 Meaningful Use Payments Made in July
Why Critical Access Hospitals in New Hampshire Have an Easier Path to MU2
Study: “Digital Divide” in MU Attestation Persists
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
